Cargando…
Epac1 Blocks NLRP3 Inflammasome to Reduce IL-1β in Retinal Endothelial Cells and Mouse Retinal Vasculature
Inflammation is an important component of diabetic retinal damage. We previously reported that a novel β-adrenergic receptor agonist, Compound 49b, reduced Toll-like receptor 4 (TLR4) signaling in retinal endothelial cells (REC) grown in high glucose. Others reported that TLR4 activates high-mobilit...
Autores principales: | Jiang, Youde, Liu, Li, Curtiss, Elizabeth, Steinle, Jena J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350318/ https://www.ncbi.nlm.nih.gov/pubmed/28348460 http://dx.doi.org/10.1155/2017/2860956 |
Ejemplares similares
-
PKA and Epac1 Reduce Nek7 to Block the NLRP3 Inflammasome Proteins in the Retinal Vasculature
por: Liu, Li, et al.
Publicado: (2022) -
Epac1 agonist decreased inflammatory proteins in retinal endothelial cells, and loss of Epac1 increased inflammatory proteins in the retinal vasculature of mice
por: Liu, Li, et al.
Publicado: (2017) -
Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
por: Jiang, Youde, et al.
Publicado: (2019) -
Epac1 and PKA agonists inhibit ROS to reduce NLRP3 inflammasome proteins in retinal endothelial cells
por: Liu, Li, et al.
Publicado: (2022) -
Epac1 Requires AMPK Phosphorylation to Regulate HMGB1 in the Retinal Vasculature
por: Jiang, Youde, et al.
Publicado: (2020)